N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes

Summary of information on human CYP enzymes: human P450 metabolism data

Rendić, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 819 · see citing works

Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions

Bertz, R., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755 · see citing works

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

Zanger, U. M., Turpeinen, M., Klein, K., & Schwab, M. G. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2291-6 · Cited by 593 · see citing works

Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance

Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038020-00002 · Cited by 508 · see citing works

Idiosyncratic Adverse Drug Reactions: Current Concepts

Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 308 · see citing works

Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 273 · see citing works

Protease Inhibitors in Patients with HIV Disease

Barry, M. G., Gibbons, S., Back, D. J., & Mulcahy, F. M. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00003 · Cited by 253 · see citing works

CYTOCHROME P450 ACTIVATION OF ARYLAMINES AND HETEROCYCLIC AMINES

Kim, D., & Guengerich, F. P. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100010 · Cited by 250 · see citing works

Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin

Kidd, R. S., Curry, T. B., Gallagher, S., Edeki, T. I., Blaisdell, J. A., & Goldstein, J. A. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00008 · Cited by 236 · see citing works

Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively

Wen, X., Wang, J.-S., Backman, J. T., Laitila, J., & Neuvonen, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.631 · Cited by 173 · see citing works

The danger hypothesis—potential role in idiosyncratic drug reactions

Pirmohamed, M., Naisbitt, D. J., Gordon, F., & Park, B. K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00255-x · Cited by 164 · see citing works

A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions

Reilly, T. P., Lash, L. H., Doll, M. A., Hein, D. W., Woster, P. M., & Svensson, C. K. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00985.x · Cited by 150 · see citing works

Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity

Naisbitt, D. J., Hough, S. J., Gill, H., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702453 · Cited by 134 · see citing works

Idiosyncratic toxicity associated with potentiated sulfonamides in the dog

Trepanier, L. A. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00576.x · Cited by 134 · see citing works

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation <i>in vivo</i>

Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., & Park, B. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704074 · Cited by 133 · see citing works

Advances in molecular toxicology–towards understanding idiosyncratic drug toxicity

Park, B. K., Kitteringham, N. R., Powell, H., & Pirmohamed, M. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00303-6 · Cited by 129 · see citing works

Comparison of the Metabolism and Toxicity of Dapsone in Rat, Mouse and Man

Tingle, M. D., Mahmud, R., Maggs, J. L., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37079-x · Cited by 125 · see citing works

Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling

Sanderson, J. P., Naisbitt, D. J., Farrell, J., Ashby, C. A., TUCKER, M., Rieder, M. J., Pirmohamed, M., Clarke, S. E., & Park, B. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5533 · Cited by 123 · see citing works

Metabolic activation in drug allergies

Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., & Pirmohamed, M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00397-8 · Cited by 122 · see citing works

Polymorphisms of human cytochrome P450 2C9 and the functional relevance

Zhou, S.-F., Zhou, Z.-W., & Huang, M. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.013 · Cited by 119 · see citing works

REDUCTION OFN-HYDROXYLATED COMPOUNDS: AMIDOXIMES (N-HYDROXYAMIDINES) AS PRO-DRUGS OF AMIDINES

Clement, B. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120005643 · Cited by 119 · see citing works

Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?

Knowles, S. R., Shapiro, L. E., & Shear, N. H. (2001) · Drug Safety · doi:10.2165/00002018-200124040-00001 · Cited by 117 · see citing works

HIV and drug allergy

Pirmohamed, M., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00006 · Cited by 103 · see citing works

Drug hypersensitivity in HIV

Phillips, E. J., & Mallal, S. A. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32825ea68a · Cited by 103 · see citing works

Idiosyncratic Drug Reactions

Pirmohamed, M., Madden, S. F., & Park, B. K. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00005 · Cited by 97 · see citing works

Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells

Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95 · see citing works

The Generation, Detection, and Effects of Reactive Drug Metabolites

Stachulski, A. V., Baillie, T. A., Park, B. K., Obach, R. S., Dalvie, D., Williams, D. P., Srivastava, A., Regan, S., Antoine, D. J., Goldring, C. E., et al. (2012) · Medicinal Research Reviews · doi:10.1002/med.21273 · Cited by 88 · see citing works

Sulfonamide Hypersensitivity: Fact and Fiction

Khan, D. A., Knowles, S. R., & Shear, N. H. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.034 · Cited by 87 · see citing works

Multiple Adduction Reactions of Nitroso Sulfamethoxazole with Cysteinyl Residues of Peptides and Proteins: Implications for Hapten Formation

Callan, H. E., Jenkins, R. E., Maggs, J. L., Lavergne, S. N., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900034r · Cited by 84 · see citing works

NADH Cytochrome b5 Reductase and Cytochrome b5 Catalyze the Microsomal Reduction of Xenobiotic Hydroxylamines and Amidoximes in Humans

Kurian, J. R., Bajad, S. U., Miller, J. L., Chin, N. A., & Trepanier, L. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072389 · Cited by 83 · see citing works

N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism

Spielberg, S. P. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353477 · Cited by 81 · see citing works

Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis

Camous, X., Calbo, S., Picard, D., & Musette, P. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.010 · Cited by 78 · see citing works

Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin

Roychowdhury, S., & Svensson, C. K. (2005) · The AAPS Journal · doi:10.1208/aapsj070480 · Cited by 78 · see citing works

The mammalian molybdenum enzymes of mARC

Ott, G., Havemeyer, A., & Clement, B. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1216-4 · Cited by 76 · see citing works

Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans

Farrell, J., Naisbitt, D. J., Drummond, N. S., Depta, J. P. H., Vilar, F. J., Pirmohamed, M., & Park, B. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050112 · Cited by 74 · see citing works

Increased Risk of Erythema Multiforme Major with Combination Anticonvulsant and Radiation Therapies

Micali, G., Linthicum, K., Cheigh, N. H., & West, D. P. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.3.223.30917 · Cited by 72 · see citing works

Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins

Manchanda, T., Hess, D. A., Dale, L., Ferguson, S. S. G., & Rieder, M. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1011 · Cited by 69 · see citing works

The Relationship Between the Disposition and Immunogenicity of Sulfamethoxazole in the Rat

Gill, H., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36867-3 · Cited by 69 · see citing works

The fourth mammalian molybdenum enzyme mARC: current state of research

Havemeyer, A., Lang, J., & Clement, B. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.608682 · Cited by 67 · see citing works

Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8 + cells by the hydroxylamine of sulfamethoxazole

Hess, D. A., Sisson, M. E., Suria, H., Wijsman, J. A., Puvanesasingham, R., Madrenas, J., & Rieder, M. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1688 · Cited by 65 · see citing works

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases

Vyas, P. M., Roychowdhury, S., Koukouritaki, S. B., Hines, R. N., Krueger, S. K., Williams, D. E., Nauseef, W. M., & Svensson, C. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105874 · Cited by 64 · see citing works

Down-Regulation of Hepatic CYP3A and CYP2C Mediated Metabolism in Rats with Moderate Chronic Kidney Disease

Velenosi, T. J., Fu, A. Y. N., Luo, S., Wang, H., & Urquhart, B. L. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045245 · Cited by 63 · see citing works

Drug Antigenicity, Immunogenicity, and Costimulatory Signaling: Evidence for Formation of a Functional Antigen through Immune Cell Metabolism

Elsheikh, A., Lavergne, S. N., Castrejón-Flores, J. L., Farrell, J., Wang, H., Sathish, J. G., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000889 · Cited by 62 · see citing works

Role of bioactivation in drug-induced hypersensitivity reactions

Sanderson, J. P., Naisbitt, D. J., & Park, B. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080107 · Cited by 61 · see citing works

Toxicophores: groups and metabolic routes associated with increased safety risk.

Williams, D. P., & Naisbitt, D. J. (2002) · PubMed · Cited by 62 · see citing works

Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests

Naisbitt, D. J. (2003) · Toxicology · doi:10.1016/j.tox.2003.09.004 · Cited by 62 · see citing works

The importance of hapten–protein complex formation in the development of drug allergy

Faulkner, L., Meng, X., Park, B. K., & Naisbitt, D. J. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000078 · Cited by 57 · see citing works

Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative

King, R. J., Teitel, C. H., Shaddock, J. G., Casciano, D. A., & Kadlubar, F. F. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00119-6 · Cited by 54 · see citing works

Carbamazepine induces multiple cytochrome P450 subfamilies in rats

Tateishi, T., Asoh, M., Nakura, H., Watanabe, M., Tanaka, M., Kumai, T., & Kobayashi, S. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00110-0 · Cited by 53 · see citing works

Isolation and Characterization of the Protein Components of the Liver Microsomal O2-insensitive NADH-Benzamidoxime Reductase

Clement, B., Lomb, R., & Möller, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19615 · Cited by 52 · see citing works

Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors

Lehmann, D. F., Hurteau, T. E., Newman, N. B., & Coyle, T. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90071-0 · Cited by 51 · see citing works

The Role of Reactive Drug Metabolites in Immune-Mediated Adverse Drug Reactions

Hess, D. A., & Rieder, M. J. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101116 · Cited by 50 · see citing works

Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts

BHAIYA, P., Roychowdhury, S., Vyas, P. M., Doll, M. A., Hein, D. W., & Svensson, C. K. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.02.006 · Cited by 48 · see citing works

Reactive Metabolites and Adverse Drug Reactions: Clinical Considerations

Knowles, S. R., Shapiro, L. E., & Shear, N. H. (2003) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:24:3:229 · Cited by 48 · see citing works

Multicenter Study of Trimethoprim/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia

Yang, J.-J., Huang, C., Liu, C.-E., Tang, H.-J., Yang, C., Lee, Y., Lee, K., Tsai, M., Lin, S., Chen, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106141 · Cited by 46 · see citing works

Rifampin Reduces Concentrations of Trimethoprim and Sulfamethoxazole in Serum in Human Immunodeficiency Virus-Infected Patients

Ribera, E., Pou, L., Solà, A. F., Campos, F., López, R. M., Ocaña, I., Ruíz-Camps, I., & Pahissa, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3238-3241.2001 · Cited by 46 · see citing works

Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins

Cribb, A. E., Pohl, L. R., Spielberg, S. P., & Leeder, J. S. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36874-0 · Cited by 46 · see citing works

Safety of Celecoxib in Individuals Allergic to Sulfonamide

Shapiro, L. E., Knowles, S. R., Weber, E., Neuman, M. G., & Shear, N. H. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00004 · Cited by 45 · see citing works

Precision Biotransformation of Emerging Pollutants by Human Cytochrome P450 Using Computational–Experimental Synergy: A Case Study of Tris(1,3-dichloro-2-propyl) Phosphate

Chai, L., Zhang, H., Song, R., Yang, H., Yu, H., Paneth, P., Kepp, K. P., Akamatsu, M., & Ji, L. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c03036 · Cited by 44 · see citing works

Idiosyncratic Drug Hepatotoxicity Revisited: New Insights from Mechanistic Toxicology

Boelsterli, U. A. (2003) · Toxicology Mechanisms and Methods · doi:10.1080/15376510309824 · Cited by 44 · see citing works

Monitoring drug–protein interaction

Yang, X.-X., Hu, Z., Chan, S. Y., & Zhou, S.-F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.08.021 · Cited by 43 · see citing works

Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients

Wang, D., Curtis, A., Papp, A. C., Koletar, S. L., & Para, M. F. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-32 · Cited by 42 · see citing works

Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells

Summan, M., & Cribb, A. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00060-1 · Cited by 42 · see citing works

Monitoring Adverse Drug Reactions to Sulfonamide Antibiotics in Human Immunodeficiency Virus–Infected Individuals

Neuman, M. G., Malkiewicz, I. M., Phillips, E. J., Rachlis, A., Ong, D., Yeung, E., & Shear, N. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200212000-00008 · Cited by 40 · see citing works

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450

Vyas, P. M., Roychowdhury, S., Khan, F. D., Prisinzano, T. E., Lamba, J. K., Schuetz, E. G., Blaisdell, J. A., Goldstein, J. A., Munson, K. L., Hines, R. N., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105858 · Cited by 39 · see citing works

N -OXIDATIVE TRANSFORMATION OF FREE AND N -SUBSTITUTED AMINE FUNCTIONS BY CYTOCHROME P450 AS MEANS OF BIOACTIVATION AND DETOXICATION

Hlavica, P. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120005646 · Cited by 39 · see citing works

Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions

Naisbitt, D. J., Olsson-Brown, A. C., Gibson, A., Meng, X., Ogese, M. O., Tailor, A., & Thomson, P. (2019) · Allergy · doi:10.1111/all.14127 · Cited by 40 · see citing works

Sulfonamide Hypersensitivity

Chow, T. G., & Khan, D. A. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08872-3 · Cited by 38 · see citing works

Characterization of biotransformation enzyme activities in primary rat proximal tubular cells

Schaaf, G., de Groene, E. M., Maas-Bakker, R. F., Commandeur, J. N. M., & Fink‐Gremmels, J. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00151-x · Cited by 38 · see citing works

CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME

Andersson, S., Hofmann, Y., Nordling, Å., Li, X., Nivelius, S., Andersson, T. B., Ingelman‐Sundberg, M., & Johansson, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002972 · Cited by 37 · see citing works

Association of drug‐serum protein adducts and anti‐drug antibodies in dogs with sulphonamide hypersensitivity: A naturally occurring model of idiosyncratic drug toxicity

Lavergne, S. N., Danhof, R., Volkman, E. M., & Trepanier, L. A. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02506.x · Cited by 35 · see citing works

TNF,LTA,HSPA1LandHLA-DRGene Polymorphisms in HIV-Positive Patients with Hypersensitivity to Cotrimoxazole

Alfirevic, A., Vilar, F. J., Alsbou, M., Jawaid, A., Thomson, W., Ollier, W., Bowman, C. E., Delrieu, O., Park, B. K., & Pirmohamed, M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.6 · Cited by 34 · see citing works

Cytochrome b5 and NADH cytochrome b5 reductase: genotype–phenotype correlations for hydroxylamine reduction

Sacco, J., & Trepanier, L. A. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283343296 · Cited by 34 · see citing works

Reductive Detoxification of Arylhydroxylamine Carcinogens by Human NADH Cytochrome b5 Reductase and Cytochrome b5

Kurian, J. R., Chin, N. A., Longlais, B. J., Hayes, K., & Trepanier, L. A. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060106t · Cited by 32 · see citing works

Mechanistic perspectives on sulfonamide-induced cutaneous drug reactions

Reilly, T. P., & Ju, C. (2002) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200208000-00004 · Cited by 32 · see citing works

Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)

Ott, G., Plitzko, B., Krischkowski, C., Reichmann, D., Bittner, F., Mendel, R. R., Kunze, T., Clement, B., & Havemeyer, A. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500174u · Cited by 31 · see citing works

Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides

Elzagallaai, A. A., Sultan, E. A., Bend, J. R., Abuzgaia, A. M., Loubani, E., & Rieder, M. J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1535 · Cited by 31 · see citing works

Plasma Ascorbate Deficiency Is Associated With Impaired Reduction of Sulfamethoxazole-Nitroso in HIV Infection

Trepanier, L. A., Yoder, A. R., Bajad, S. U., Beckwith, M. D., Bellehumeur, J. L., & Graziano, F. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00007 · Cited by 31 · see citing works

Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions

Lee, M. D., Ayanoĝlu, E., & Gong, L. (2006) · Xenobiotica · doi:10.1080/00498250600861785 · Cited by 31 · see citing works

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase

Ogese, M. O., Jenkins, R. E., Maggs, J. L., Meng, X., Whitaker, P., Peckham, D. G., Faulkner, L., Park, B. K., & Naisbitt, D. J. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500458k · Cited by 29 · see citing works

Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method

Wei, Y., Yang, L. C., Zhang, X., Sui, D., Wang, C.-S., Wang, K., Shan, M., Guo, D., & Wang, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078444 · Cited by 28 · see citing works

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity

Sacco, J., Abouraya, M., Motsinger‐Reif, A. A., Yale, S. H., McCarty, C. A., & Trepanier, L. A. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328357a735 · Cited by 27 · see citing works

Primary aromatic amines: their N-oxidative bioactivation

Hlavica, P., Golly, I., Lehnerer, M., & Schulze, J. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701600805 · Cited by 27 · see citing works

NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes

Trepanier, L. A., & Miller, J. L. (2000) · Xenobiotica · doi:10.1080/00498250010013908 · Cited by 26 · see citing works

Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management

Trepanier, L. A. (1999) · Veterinary Dermatology · doi:10.1046/j.1365-3164.1999.00173.x · Cited by 25 · see citing works

Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes

Khan, F. D., Roychowdhury, S., Nemes, R., Vyas, P. M., Woster, P. M., & Svensson, C. K. (2005) · Toxicology · doi:10.1016/j.tox.2005.10.002 · Cited by 24 · see citing works

The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)

Winter, H. R., TRAPNELL, C., Slattery, J. T., JACOBSON, M., GREENSPAN, D., HOOTON, T., & Unadkat, J. D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.016 · Cited by 24 · see citing works

METABOLISM-BASED DRUG INTERACTIONS INVOLVING ORAL AZOLE ANTIFUNGALS IN HUMANS*

Benedetti, M. S., & Bani, M. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101941 · Cited by 24 · see citing works

Multiple cytochrome P-450 subfamilies are co-induced with P-glycoprotein by both phenothiazine and 2-acetylaminofluorene in rats

Tateishi, T., Nakura, H., Asoh, M., Watanabe, M., Tanaka, M., Kumai, T., & Kobayashi, S. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00374-7 · Cited by 24 · see citing works

Evidence for the formation of 6PPD-quinone from antioxidant 6PPD by cytochrome P450

Jin, L., Cheng, S., Ge, M., & Ji, L. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136273 · Cited by 23 · see citing works

Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients

Kagaya, H., Miura, M., Niioka, T., Saito, M., Numakura, K., Habuchi, T., & Satoh, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05037-11 · Cited by 23 · see citing works

Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children

Thompson, E. J., Wu, H., Maharaj, A. R., Edginton, A. N., Balevic, S. J., Cobbaert, M., Cunningham, A. P., Hornik, C. P. V., & Cohen‐Wolkowiez, M. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-00733-1 · Cited by 23 · see citing works

Effect of methamphetamine on cytochrome P450 activity

Dostálek, M., Juřica, J., Pistovčáková, J., Hanesová, M., Tomandl, J., Linhart, I., & Šulcová, A. (2007) · Xenobiotica · doi:10.1080/00498250701652877 · Cited by 22 · see citing works

Liver Damage Induced by Bile Duct Ligation Affects CYP Isoenzymes Differently in Rats

Tateishi, T., Watanabe, M., Nakura, H., Tanaka, M., Kumai, T., & Kobayashi, S. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01403.x · Cited by 22 · see citing works

Association Analysis of Drug Metabolizing Enzyme Gene Polymorphisms in AIDS Patients with Cutaneous Reactions to Sulfonamides

Wolkenstein, P., Loriot, M., Flahault, A., Cadilhac, M., Caumes, É., Eliaszewicz, M., Beaune, P. H., Roujeau, J., & Chosidow, O. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23939.x · Cited by 21 · see citing works

The effects of cotrimoxazole or tenofovir co‐administration on the pharmacokinetics of maraviroc in healthy volunteers

Abel, S., Russell, D., Whitlock, L. A., Ridgway, C. E., & Muirhead, G. J. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03135.x · Cited by 21 · see citing works

Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation

Miller, J. L., & Trepanier, L. A. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0424-y · Cited by 21 · see citing works

Effect of human pharmaceuticals common to aquatic environments on hepatic CYP1A and CYP3A-like activities in rainbow trout (Oncorhynchus mykiss): An in vitro study

Burkina, V., Sakalli, S., Pilipenko, N. D., Žlábek, V., & Zamaratskaia, G. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.04.080 · Cited by 19 · see citing works

Immunological principles of T-cell-mediated adverse drug reactions in skin

Naisbitt, D. J., Pirmohamed, M., & Park, B. K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.109 · Cited by 19 · see citing works

Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites

Choquet‐Kastylevsky, G., Santolaria, N., Tédone, R., Aujoulat, M., & Descotes, J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(00)00313-1 · Cited by 19 · see citing works

Short Communication Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes:

Bioanalysis, I., & Metabolites, S. (2008)

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine

Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65 · see citing works

The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation

Gill, H. J., Tjia, J. F., Kitteringham, N. R., Pirmohamed, M., Back, D. J., & Park, B. K. (1999) · Pharmacogenetics · doi:10.1097/00008571-199902000-00007 · Cited by 48 · see citing works

Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes

Clement, B., Behrens, D., Amschler, J., Matschke, K., Wolf, S., & Havemeyer, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.028 · Cited by 14 · see citing works

Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites

Sanderson, J. P., Hollis, F. J., Maggs, J. L., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021246 · Cited by 8 · see citing works